Joseph J. Eron, Jr. , MD
Division of Infectious Diseases
University of North Carolina at Chapel Hill
Joseph J. Eron, Jr., MD is a Professor of Medicine in the Division of Infectious Diseases at the University of North Carolina at Chapel Hill. He received his Infectious Diseases and HIV training at Massachusetts General Hospital under Drs. Martin Hirsch and Richard DAquila. He is the Principal Investigator of the HIV/AIDS Clinical Research Unit at UNC-CH and the Director of the Clinical Core for the UNC Center for AIDS Research (CFAR). He has been part of the AIDS Clinical Trials Group since 1993 and has held multiple leadership positions including Chair of the Optimization of ART (OpART) Committee and the Cure Transformative Science Group. He is the Principal Investigator of the UNC Clinical trials Unit with sites in Chapel Hill, Greensboro, Lilongwe Malawi and Hanoi Vietnam. In addition, he is a leader of the UNC Acute HIV Infection research team and is a collaborator in the UNC HIV Cure initiative. Over the last 10 years, Dr. Eron has led the development of the UNC HIV CFAR Clinic Cohort that includes over 3500 HIV infected individuals and has active collaboration and membership in the NA ACCORD and CNICS cohorts. Dr. Eron has over 350 publications in peer-reviewed journals focusing on antiretroviral therapy, resistance, pharmacology, transmission and HIV persistence and disruption of latency. Recent work has included publications from the UNC CFAR HIV Clinical Cohort, the AIDS Clinical Trials Group, HPTN 052 and IAS-USA HIV treatment guidelines in JAMA 2018. Dr. Eron has worked extensively in the area of HIV drug development and led or participated in original studies of many antiretroviral therapies. He also continues as an active HIV and Infectious Disease clinician. He was awarded the HIVMA HIV Clinical Educator Award in 2013. He is now Vice Chief of the Division of Infectious Diseases and was recently elected Vice Chair of the AIDS Clinical Trials Group (ACTG). He lives in Chapel Hill with his wife and family. He has four daughters, three sons and four grandchildren.
This meeting series is jointly provided by Global Education Group and Integritas Communications. This meeting series is supported by an independent educational grant from Gilead Sciences, Inc.
We would like to thank the American Academy of HIV Medicine (AAHIVM) for their collaboration and support.